¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antigen"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antigenic variation
    Ç׿øº¯ÀÌ(ù÷ê«Ü¨ì¶).
  • antigenicity
    Ç׿ø¼º(ù÷ê«àõ).
  • antigenotherapy
    Ç׿ø¿ä¹ý.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • immunogen (antigen)
    ¸é¿ª¿ø(Øóæ¹ê«).
  • inaccessible antigen
    ¿ø°ÝÇ׿ø(êÀ̰ù÷ê«), ÀáÀçÇ׿ø.
  • incomplete antigen
    ºÒ¿ÏÀüÇ׿ø.
  • pilus protein antigen
    ¼¶¸ð´Ü¹éÁúÇ׿ø
  • polysaccharide antigen
    ´Ù´çüÇ׿ø
  • polyvalent antigen
    ´Ù°¡Ç׿ø
  • private antigen
    °³º° Ç׿ø(ù÷ê«)
  • processing, antigen
    Ç׿øÃ³¸®
  • prostate specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
  • prostate-specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø(îñí¡àÍ÷åì¶ù÷ê«)
  • prostate-specipic antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
  • prostatic specific antigen
    Àü¸³¼± ƯÀÌÇ׿ø
  • protective antigen
    ¹æ¾îÇ׿ø(¡­ù÷ê«).
  • public antigen
    °øÅëÇ׿ø
  • public antigen
    ÀϹÝÇ׿ø, °øÅëÇ׿ø cf.private antigen
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic diversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ).
  • antigenic drift
    Ç׿ø¼Òº¯ÀÌ
  • antigenic drift, influenza viruses
    Ç׿ø¼Òº¯ÀÌ(ù÷ê«á³Ü¨ì¶)
  • antigenic mimicry
    Ç׿øÀ¯»ç¼º
  • antigenic profile
    Ç׿ø(ù÷ê«)ÇÁ·ÎÇÊ.
  • antigenic reversion
    Ç׿øº¹±Í(ù÷ê«ÜÖÏý).
  • antigenic shift
    Ç׿ø´ëº¯ÀÌ
  • antigenic shift
    Ç׿øº¯ÀÌ
  • antigenic shift, influenza viruses
    Ç׿ø´ëº¯ÀÌ(¡­ÓÞܨì¶)
  • antigenic specificity
    Ç׿øÆ¯À̼º(ù÷ê«÷åì¶àõ).
  • antigenic stimulation
    Ç׿ø¼ºÀÚ±Ø
  • antigenic structure
    Ç׿ø±¸Á¶(¡­Ï°ðã).
  • antigenic transformation
    Ç׿øº¯È¯(ù÷ê«Ü¨üµ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • nucleoprotein antigen
    ÇÙ»êÇ׿ø
  • occult antigen
    ÀáÀçÇ׿ø
  • oncofetal antigen
    Á¾¾çžƼº Ç׿ø(ðþåË÷Ãä®àõ ù÷ê«)
  • organ specific antigen
    ±â°ü<Àå±â>ƯÀÌÇ׿ø(¡­÷åì¶ù÷ê«).
  • pancreatic oncofetal antigen
    ÃéÀåÁ¾¾ç(¼º)žƼº Ç׿ø
  • particulate antigen
    ÀÔ»óÇ׿ø(í£ßÒù÷ê«).
  • pilus protein antigen
    ¼¶¸ð´Ü¹éÁúÇ׿ø
  • polysaccharide antigen
    ´Ù´çüÇ׿ø
  • polyvalent antigen
    ´Ù°¡Ç׿ø
  • private antigen
    °³º° Ç׿ø(ù÷ê«)
  • processing, antigen
    Ç׿øÃ³¸®
  • prostate specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
  • prostate-specific antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø(îñí¡àÍ÷åì¶ù÷ê«)
  • prostate-specipic antigen
    Àü¸³¼±Æ¯ÀÌÇ׿ø
  • prostatic specific antigen
    Àü¸³¼± ƯÀÌÇ׿ø
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AAR active avoidance reaction; acute articular rheumatism; antigen-antiglobulin reaction
AB abdominal; abnormal; abortion; Ace bandage; active bilaterally; aid to the blind; alcian blue; alert...
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
ABL abetalipoproteinemia; acceptable blood loss; African Burkitt lymphoma; Albright-Butler-Lightwood [sy...
ABP actin-binding protein; ambulatory blood pressure; American Board of Pedodontics; American Board of P...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
CA 19-9 Carbohydrate Antigen 19-9
CA Carbohydrate antigen
CA 15-3 Carbohydrate antigen 15-3
CEA Carcino Embryonic Antigen
CEA Carcinoembryonal antigen
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
O-antigen polymerase <enzyme> Involved in the binding of o-antigen repeat units and in polymerizing into the o-antigen chain; mw 43.7 kD; genbank x71970
Registry number: EC 2.4.1.-
Synonym: rfc protein, s. Flexneri, rfc gene product, o-antigen polymerase, shigella, o-antigen polymerase, pseudomonas, rfc protein, pseudomonas, o-antigen polymerase, e. Coli
(26 Jun 1999)
organ-specific antigen A heterogenetic antigen with organ specificity; e.g., in addition to species-specific antigen, kidney of one species contains antigen that is identical to that in kidney of other species.
Synonym: tissue-specific antigen.
(05 Mar 2000)
Tac antigen An antigenic determinant of the human interleukin 2 receptor that is identified by a murine monoclonal antibody, anti-Tac. Binding of this antigen prevents the proliferation of T-cells, which is normally stimulated by binding interleukin-2.
(05 Mar 2000)
T antigen <molecular biology> Proteins coded by viral genes that are expressed early in the replication cycle of papovaviruses such as SV40 and polyoma. Essential for normal viral replication, they are also expressed in nonpermissive cells transformed by these viruses.
Originally detected as Tumour antigens by immunofluorescence with antisera from tumour bearing animals. SV40 has two, large T and small t, polyoma has three, large, middle and small. Appear to be collectively responsible for transformation by these viruses.
(14 Oct 1997)
T-cell antigen receptors Receptors present on T-cells that interact with both processed antigen and major histocompatibility antigens simultaneously.
(05 Mar 2000)
T-dependent antigen An antigen that requires T helper cells in addition to appropriate B-cells. Most antigens are T-dependent.
(05 Mar 2000)
theta antigen A surface glycoprotein that is present on thymocytes of mice and rats.
(05 Mar 2000)
thymus-independent antigen An antigen that does not require T helper cell activation in order for the host's B-cells to be stimulated. Repeating polymers such as polysaccharides are examples of T-independent antigens.
(05 Mar 2000)
tissue polypeptide antigen Serological tumour marker composed of a molecular complex of cytokeratins 8, 18, and 19. It is used in the diagnosis and staging of bronchogenic carcinoma.
(12 Dec 1998)
tissue-specific antigen A heterogenetic antigen with organ specificity; e.g., in addition to species-specific antigen, kidney of one species contains antigen that is identical to that in kidney of other species.
Synonym: tissue-specific antigen.
(05 Mar 2000)
TL antigen <immunology> The mouse antigens coded for by the TLa complex, in normal animals only found on intrathymic lymphocytes, but also seen on leukaemic cells (hence, thymus leukaemia antigen) in certain forms of the disease in mice. The molecules have structures similar in some ways to Class I MHC products but are disulphide bonded tetramers of two 45 kD chains and two 12 kD chains of _2 microglobulin type.
(18 Nov 1997)
transplantation antigen <immunology> Any antigen that is antigenically active in graft rejection. In practice the major histocompatibility complex and the H Y antigens and to a lesser extent minor histocompatibility antigens.
(18 Nov 1997)
Epithelial membrane antigen <cell biology> Heavily glycosylated membrane glycoprotein. Encoded by the MUC 1 gene, has a molecular weight of around 300 kD, more than half of which is O linked glycan. There is a 69 residue cytoplasmic domain and the extracellular domain may extend hundreds of nanometres beyond the plasma membrane, the increased expression in carcinoma cells may reduce the adhesion and mask antigenic properties of the cells. Similar functions are ascribed to ASGP, epiglycanin and leucosialin.
(18 Nov 1997)
tumour-associated antigen Antigens that are highly correlated with certain tumour cells. They are not usually found, or are found to a lesser extent, on normal cells.
(05 Mar 2000)
tumour specific antigen <immunology, oncology> Antigen on tumour cells detected by cell-mediated immunity. For virus transformed cells TSTA (unlike T antigen) is found to differ for different individual tumours induced by the same virus. May consist of fragments of T antigens exposed at the cell surface.
(18 Nov 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 8
  • Antigens, CD34 - »õâ Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood system is restricted to a small number of progenitor cells in the bone marrow.
    Synonyms : CD34 Antigen, Antigen, CD34
  • Antigens, CD36 - »õâ Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.
    Synonyms : Adipocyte Membrane Protein p88, CD36 Antigen, CD36 Antigen (Collagen Type I Receptor, Thrombospondin Receptor), CD36 Fatty Acid Transporter, CD36 Protein, FAT (Fatty Acid Translocase) - CD36 Antigen, GPIIIb Platelet Glycoprotein, GPIV Platelet Glycoprotein
  • Antigens, CD38 - »õâ A bifunctional enzyme that catalyzes the synthesis and HYDROLYSIS of CYCLIC ADP-RIBOSE (cADPR) from NAD+ to ADP-RIBOSE. It is a cell surface molecule which is predominantly expressed on LYMPHOID CELLS and MYELOID CELLS.
    Synonyms : ADPR Cyclase CD38, ADPR Cyclase T10, Acute Lymphoblastic Leukemia Cells Antigen CD38, CD38 Antigen, Lymphocyte Differentiation Antigen CD38, NIM-R5 Antigen, T10 Antigen, Antigen, T10, CD38, ADPR Cyclase, Cyclase CD38, ADPR, Cyclase T10, ADPR, NIM R5 Antigen
  • Antigens, CD4 - »õâ 55-kDa antigens found on HELPER-INDUCER T-LYMPHOCYTES and on a variety of other immune cell types. CD4 antigens are members of the immunoglobulin supergene family and are implicated as associative recognition elements in MAJOR HISTOCOMPATIBILITY COMPLEX class II-restricted immune responses. On T-lymphocytes they define the helper/inducer subset. CD4 antigens also serve as INTERLEUKIN-15 receptors and bind to the HIV receptors, binding directly to the HIV ENVELOPE PROTEIN GP120.
    Synonyms : CD4 Antigen, Receptors, Surface CD4, Surface CD4 Receptor, Antigen, CD4, Antigens, T-Cell T4, CD4 Receptor, Surface, CD4 Receptors, Surface, Surface CD4 Receptors, T-Cell T4 Antigens, T4 Antigens, T Cell
  • Antigens, CD40 - »õâ A member of the tumor necrosis factor receptor superfamily with specificity for CD40 LIGAND. It is found on mature B-LYMPHOCYTES and some EPITHELIAL CELLS, lymphoid DENDRITIC CELLS. Evidence suggests that CD40-dependent activation of B-cells is important for generation of memory B-cells within the germinal centers. Mutations of the gene for CD40 antigen result in HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 3. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS.
    Synonyms : CD40 Antigen, CDw40 Antigen, TNFRSF5 Receptor, Antigen, CD40, Antigen, CDw40, Receptor, TNFRSF5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
antigen Any foreign or "non-self" substance that, when introduced into the body, causes the immune system to create an antibody.
Ãâó: www.i-bio.gov.uk/UkBioportal/Beginners/html/glossa...
antigen Any piece of a substance (foreign protein, toxin, bacteria) that can induce a specific immune response or react to a specific antibody or T-cell.
Ãâó: www.aidsinfonyc.org/hivplus/issue9/report/glossary...
antigen-presenting cell A cell that can process an infectious agent and present pieces of it (antigens) to T-cells. Dendritic cells and macrophages function as APCs.
Ãâó: www.aidsinfonyc.org/hivplus/issue9/report/glossary...
antigen g. the acquisition by cells of new antigenic determinants not normally present or not normally accessible in the parent tissue.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
antigen p. the activity in which macrophages ingest and partially digest antigens and then present the processed antigen on their surfaces to B and T lymphocytes. The presented antigen is more immunogenic than unprocessed antigen, possibly because it has been broken down into pieces more easily recognized by B and T cells, because it remains on the surface of the presenting cell for a long time, or because it is presented in association with self MHC antigen and thus able to stimulate helper T cells. The principal antigen-presenting cells are dendritic cells in B-dependent areas of lymphoid tissues, interdigitating cells in T-dependent areas, and Langerhans cells in the epidermis.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á